Cold atmospheric plasma (CAP) is a promising option for the treatment of --node assay (according to the Organisation for Economic Co-operation and Development protocol) to evaluate the kINPen MED's potential to trigger skin sensitization. Our results showed that 25 s of CAP exposure did not induce skin sensitization compared with the vehicle control (acetone/olive oil mixture). The CAP-treated group had a stimulation index (SI) of 0.76, which device did not cause any harmful sensitization or irritation in a murine model.
I. INTRODUCTION
Although physical plasma is commonly referred to as a nonclassical state of matter, describing an ionized, high-energy proportionate in a gas, the development of tissuetolerable cold atmospheric plasma (CAP) has opened a wide range of possible biological and medical applications. 1 These applications of CAP demonstrate excellent microbi-2,3
4,5 and the ability to induce apoptosis but not necrosis in cancer cells. [6] [7] [8] Plasma medicine is a fast-developing area of medical research. 9 sterilization, 10,11 wound healing, dental therapy, 12 dermatology, 13 and anticancer treat-
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ment. 8 Although the interaction between CAP and living tissue is not yet fully understood, a comprehensive medical CAP application may be possible in the future. Several and safety of CAP. Consequently, in 2013, the European Commission approved and granted CE markings (class IIb medical device) for two plasma sources: kINPen MED (Neoplas Tools GmbH, Greifswald, Germany) and PlasmaDerm (Cynogy, Duderstadt, Germany).
14 Because the irritative and sensitizing potency of CAP (particularly kINPen MED transportable plasma) has not yet been tested and is a prerequisite for CAP application on the skin, wounds, and mucous membranes, this study analyzes this potency for the Methods (ICCVAM) and the Organisation for Economic Co-operation and Development (OECD) have approved experimental protocols such as the local lymph node assay suitable for detecting dose-dependent skin sensitization. 15, 16 In this setting, lymphocyte proliferation in local lymph nodes is measured by the amount of adenosine triphosphate (ATP), which correlates highly with the total cell number. 17 In contrast with allergic contact dermatitis, irritant contact dermatitis is caused by 17, 18 The plasma jet generates a well-characterized CAP that does not seem to be dangerous from either a physical (temperature, ultraviolet [UV] radiation, ozone) or biological point of view (cytotoxicity, depth of penetration, mutagenicity). 19, 20 Although existing studies have not yet demonstrated sensitization after the application of CAP to intact skin, 21 there are currently no in vivo studies that uncover the possible sensitization potential of CAP by exploring the local lymph node reaction. CAP is not a conventional species (nitric oxide, nitrogen dioxide) and reactive oxygen species (ozone, superoxide, and nitrogen species play a key role in both inducing sensitization 22 and mediating the 23, 24 tion, generated by an atmospheric pressure argon plasma jet (kINPen MED), in vivo on the basis of the LLNA:DA assay.
II. MATERIALS AND METHODS

A. CAP Generation
CAP was generated by the kINPen MED atmospheric pressure argon plasma jet (Neoplas Tools), which is accredited as a medical device. The hand-held unit contains a mounted rod-like electrode that is shielded by a dielectric capillary. Using 4 L/min of generating a sinusoidal voltage with a frequency of about 1 MHz.
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B. CAP Treatment Regimen In Vivo
Following the LLNA guidelines, this experiment was carried out using female 9-weekold CBA/J mice (Charles River Laboratories, Sulzfeld, Germany) with access to food and water ad libitum. 25 The animals were randomly divided into four treatment regimens cinnamic aldehyde in acetone/olive oil (4:1, v/v)] or a liquid negative control [acetone/ control was applied to the dorsum of each ear. -lenged with 10 μL of liquid per ear, the second two groups were exposed to gaseous matter for 25 s with a capillary tip to skin distance of 5 mm. The treatment was performed on days 1, 2, 3, and 7 ( Fig. 1B) . One hour prior to treatment, mice were anesthetized -ricular lymph nodes were sampled (Fig. 1C) . The local ethics committee approved the mouse experiments (application number 7221.3.-1.-010/13). Animal health and weight was monitored daily.
C. ATP Determination
Grand Island, NY, USA) and weighed. The tissue samples were then mashed, homogenized in 1 mL PBS, and diluted 1:10 in PBS again. Then 100 μL was mixed with bio-(Eppendorf, Hamburg, Germany), shaken, and incubated at room temperature for 10 (Tecan, Männedorf, Switzerland). The determined relative luminescence (RLU) is linearly dependent on ATP content. Thus, a standard curve was prepared for calculating ATP concentration. Due to the postmortem instability of ATP, care was taken not to exceed a period of 20 min from euthanasia to substrate addition. 26 After the animals were euthanized and the lymph nodes were prepared, a piece of each ear was retrieved using a punch (4-mm diameter; PFM Medical AG, Köln, Germany) and was then embedded in TissueTek (Sakura Finetek, Alphen aan den Rijn, The Netherlands) and stored in liquid nitrogen. Thin sections of the ears were cut and incubated with hematoxylin and eosin (Sigma, St. Louis, MO, USA), and samples were then Germany).
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Statistical analysis was carried out using GraphPad Prism software (version 6.07; was applied to compare lymph node weight, RLU values, and ATP concentrations. The between the test groups and to calculate the dimensionless stimulation index (SI). Therefore, the mean RLUs of all four groups were divided by the mean of the liquid negative 
A. Repeated CAP Treatment Did Not Provoke Persistent Local Skin Reaction
Instantaneous to the application of each substance, mice developed local short-lasting hyperemia, but this hyperemia advanced to a slight local erythema only in the positive of the animals.
In support of this, no abnormality in histological skin architecture was detected after exposure to CAP or one of the negative controls, whereas the positive control substance led to a higher cell number, cell swelling, and locally disrupted stratum corneum (Fig.  2) .
B. Characteristics of Skin Sensitization Were Not Present In Vivo after CAP Treatment
resulting in larger and heavier structures. Therefore, retroauricular lymph nodes were weighed prior to processing. The mean weight was 4.3 ± 0.7 mg for the positive control and 3.2 ± 0.3 mg for the liquid negative control. Both CAP treatment and argon led to even lower weights of 3.0 ± 0.2 mg and 2.7 ± 0.2 mg, respectively (Fig. 3A) . In addition to the lymph node weight the cell number and total amount of ATP, respectively increases due to cell proliferation. The standard curve illustrates the linear x + 647.5 (Fig. 3B) . The ATP concentration was 272 ± 213.4 μg/mL for the positive control and 57.45 ± 11.64 μg/mL for the liquid negative control. As above, either CAP treatment (31.23 ± 11.37 μg/mL) or argon treatment only (10.66 ± 2.99 μg/mL) resulted in less 
A u t h o r P r o o f
rule, in vitro even necrosis of nonmalignant cells. 27, 28 Potentially harmful agents (especially reactive oxygen species, UV radiation, ions, and electrons) were present in CAP and could possibly mediate skin sensitization.
Penetration of the skin barrier is a basic requirement for skin sensitization by exogenous irritants. For the kINPen MED, it has been shown that 3 s of treatment administered to intact human skin induced protein alterations in a penetration depth of the tissue of 25 μm, 29 suggesting the possibility of inducing sensitization. The high number 
could be compared on the basis of their output characteristics. In this setting, we treated UV dose is below the minimal erythemal dose (MED) for an average European person. MED is a term used to describe the erythemal potential of UV radiation, and 1 MED unexposed human skin, which varies between 200 and 500 J/m2 among the European population.
30 From this point of view, the application of CAP seems to be completely nonhazardous. In addition, CAP generated by the kINPen MED causes peak ozone conradius of approximately 5 mm. 31, 32 It is well known that the lungs are highly susceptible to oxidative stress caused by ozone pollution 33 ; by contrast, the human skin seems to be naturally resistant to ozone. Nevertheless, Valacchi et al. 34 showed that the skin of mice developed oxidative stress after exposure to 8 ppm of ozone for 2 h in a chamber.
As shown previously by Daeschlein et al., 35 with an older version of kINPen MED did not irritate the skin. In this study, the therapy procedure led to increased lymph node weight, ATP concentration, and SI in the positive control group but not in CAP-or argon-treated animals, indicating the suitability of argon-based CAP. Even in a comparison between CAP treatment and argon, the CAP SI These results are in line with observations of several clinical studies to assess skin toleration of CAP.
20,21,36
Our study has some limitations. According to Paracelsus, who pronounced that the setting of CAP assembled by the kINPen MED. 37 Next, according to the LLNA:DA protocol, limitations of gaseous CAP application were compared to the liquid positive a positive control because results are typically positive and notably reproducible, 38 differences in the sensitization potency of gaseous and liquid states of aggregation cannot vehicle substances). 39 Finally, CAP treatment was carried out on an intact skin barrier. This study design allows no statement of the reaction in altered or disturbed skin barrier function, such as chronic wounds or dermatologic diseases, as they show per se a proin- 40 However, local recurrent CAP application, generated invasion by inhibition of chemokine expression in a murine model of atopic dermatitis,
41
V. CONCLUSION in vivo
skin to be safe in this respect, as neither histological skin damage nor local lymphocyte A u t h o r P r o o f proliferation was detectable. Based on these results and clinical experience, therapeutic CAP treatment (at least, that generated by kINPen MED) seems to be unobjectionable from an immunologic point of view. As it is a long way from the bench to the bedside, further research is necessary to prove whether the high concentrations of ozone near the the tissue. Our study provides promising results, as we could not detect any abnormal proliferation activity in the local skin or lymph nodes, substantiating current assessment of risks in CAP application.
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